|Coriolus Versicolor mushroom. Image: Chris Moody|
At that time I was disillusioned by conventional medicine and intrigued by the potential of TCVM.
We've been using an integrative approach to our dogs' health since. That's why I find the potential use of a TCVM supplement in place of standard chemotherapy fascinating and exciting.
Splenic hemangiosarcoma has poor survival prognosis even with surgery and chemotherapy. This clinical trial is the next phase of research with I'm Yunity supplement, comparing its effects to those of standard chemotherapy in dogs with splenic hemangiosarcoma.
The supplement is derived from a mushroom, Coriolus Versicolor, which was first studied in 2012 and the results were promising for longer survival times in dogs treated with this supplement. That is quite promising. Quite often a study sounds very exciting but then one never hears about it again.
If I had a dog diagnosed with hemangiosarcoma, I'd be all over this one.
Further evaluation of the benefits of a Traditional Chinese Medicine supplement for dogs with splenic hemangiosarcoma